Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Hands-on Microscopy Discovery with the Experts

Published: Thursday, August 07, 2014
Last Updated: Thursday, August 07, 2014
Bookmark and Share
Olympus will be exhibiting at three major European microscopy meetings over the next month, offering delegates the chance to personally experience microscopy solutions spanning a wide range of applications, from routine pathology to high-end advanced research.

Providing the chance to discover the latest microscopy solutions in person, Olympus will be at the major microscopy meetings in Europe over the next month. With highly trained specialists on booth at each event, delegates will benefit from comprehensive demonstrations and expert advice and insight for all application requirements.

At the 26th European Congress of Pathology (ECP) 2014, 30 August - 3 September in London, stand 5, Olympus will exhibit its range of microscope systems and accessories dedicated to pathology, which can enhance the workflow of both research and diagnostic centres alike.

The BX3 range of upright microscope offers complete flexibility and ergonomics, with each user able to set up the microscope to match their posture.

The BX63 system on display will also feature the unique dual chip Olympus DP80 digital camera which has both color and monochrome capability allowing joint color and fluorescent imaging in pathology applications.

Also on display will be the Olympus VS120 virtual slide scanner that creates a “virtual slide” high-resolution image of the complete specimen at a range of magnifications. This can be stored on a central server, enabling instant access and simultaneous viewing anywhere in the world, making it suitable for remote diagnosis and teaching.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,400+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Potential “Good Fat” Biomarker
New method to measure the activity of energy consuming brown fat cells could ease the testing weight loss drugs.
MicroRNA Pathway Could Lead to New Avenues for Leukemia Treatment
Cancer researchers at the University of Cincinnati have found a particular signaling route in microRNA (miR-22) that could lead to targets for acute myeloid leukemia, the most common type of fast-growing cancer of the blood and bone marrow.
Soy Shows Promise as Natural Anti-Microbial Agent
Soy isoflavones and peptides may inhibit the growth of microbial pathogens that cause food-borne illnesses, according to a new study from University of Guelph researchers.
Doubling Down on Dengue
HMS researchers have discovered two ways a compound blocks dengue virus.
Soy Shows Promise as Natural Anti-Microbial Agent
Researchers from University of Guelph show that soy isoflavones and peptides could be used to reduce microbial contamination of food.
AstraZeneca to Sequence 2 Million Genomes in Search for New Drugs
Company launches integrated genomics approach which aims to transform drug discovery and development.
Unique Model for Studying ALS
Unique mouse model will allow researchers to better study the genetic origins and potential treatments of ALS.
Targeting an ‘Undruggable’ Cancer Gene
RAS genes are mutated in more than 30 percent of human cancers and represent one of the most sought-after cancer targets for drug developers.
Biomarkers for Profiling Prostate Cancer Patients
Exiqon A/S has announced the publication of validation of prognostic microRNA biomarkers for the aggressiveness of prostate cancer in independent cohorts.
Improving Engineered T-Cell Cancer Treatment
Purdue University researchers may have figured out a way to call off a cancer cell assassin that sometimes goes rogue and assign it a larger tumor-specific "hit list."
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!